文献速递前列腺癌

组织学前列腺萎缩合并炎症与活检标本中前列腺癌风险降低相关

The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-06-06

基于REDUCE研究中6132名50-75岁男性,基线活检阴性后2年重复活检,评估同一次活检及同一活检芯内前列腺萎缩(PA)和慢性前列腺炎症(CPI)与前列腺癌风险及分级的关系。结果显示PA、CPI及两者同时存在均与2年重复活检前列腺癌风险降低相关,且同一活检芯内同时存在两者风险更低,并与高级别前列腺癌风险降低相关。

要点

  • 基线活检中PA、CPI及两者同时检出率分别为9.5%、17.4%和59.9%。
  • 与两者均无相比,PA(OR=0.73)、CPI(OR=0.72)及两者同时(OR=0.54)与2年重复活检前列腺癌风险降低相关。
  • PA和CPI同时位于同一活检芯内者前列腺癌风险更低(多变量OR=0.73),且与高级别前列腺癌风险降低相关。

核心结论

  • 基线活检中同时存在PA和CPI,尤其是同一活检芯内,与前列腺癌风险及分级降低相关。
  • PA和CPI的存在及拓扑分布可用于前列腺癌风险分层。

研究设计与样本

  • 回顾性分析REDUCE研究(度他雄胺减少前列腺癌事件研究)中6132名50-75岁男性,基线活检阴性后2年重复活检。
  • PA、CPI和前列腺癌由中心病理学确定。
  • 采用χ2检验和逻辑回归评估基线PA和CPI与2年重复活检癌症状态及分级的关系,并控制临床病理特征。

主要发现

  • 基线活检中PA、CPI及两者同时检出分别为583例(9.5%)、1063例(17.4%)和3675例(59.9%)。
  • 与既无PA也无CPI的活检相比,PA(OR=0.73,95%CI=0.57-0.93)、CPI(OR=0.72,95%CI=0.58-0.88)及两者同时(OR=0.54,95%CI=0.45-0.64)与2年重复活检前列腺癌风险降低相关,多变量分析结果相似。
  • 在同时有PA和CPI的受试者中,同一活检芯内同时存在两者相比不同活检芯内存在两者,前列腺癌风险更低(单变量OR=0.68,95%CI=0.51-0.91;多变量OR=0.73,95%CI=0.54-0.99)。
  • PA和CPI组合与高级别前列腺癌风险降低相关。

关键数值与推荐

  • 基线活检中PA检出583例(9.5%)、CPI检出1063例(17.4%)、两者同时检出3675例(59.9%)。
  • 与两者均无相比,PA的OR=0.73(95%CI=0.57-0.93),CPI的OR=0.72(95%CI=0.58-0.88),两者同时的OR=0.54(95%CI=0.45-0.64)。
  • 同一活检芯内同时存在PA和CPI相比不同活检芯内存在两者:单变量OR=0.68(95%CI=0.51-0.91),多变量OR=0.73(95%CI=0.54-0.99)。

临床怎么用

  • PA和CPI的存在及拓扑分布可用于前列腺癌风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate whether the presence of both prostate atrophy (PA) and chronic prostate inflammation (CPI) in the same biopsy and in the same biopsy core are associated with prostate cancer (PCa) risk and grade in repeat biopsies. METHODS: Retrospective analyses of 6132 men who were 50-75 years old undergoing 2-year repeat prostate biopsy after a negative baseline biopsy for PCa in the REduction by DUtasteride of prostate Cancer Events (REDUCE) study. PA, CPI and PCa were determined by central pathology. The association of baseline PA and CPI with 2-year repeat biopsy cancer status and grade was evaluated with χ2 test and logistic regression controlling clinicopathological features. RESULTS: PA, CPI and both were detected in 583 (9.5%), 1063 (17.4%) and 3675 (59.9%) baseline biopsies, respectively. Compared with biopsies with neither PA nor CPI, the presence of PA (odds ratio (OR)=0.73, 95% confidence interval (CI)=0.57-0.93), CPI (OR=0.72, 95% CI=0.58-0.88) and both (OR=0.54, 95% CI=0.45-0.64) were associated with lower PCa risk in the 2-year repeat prostate biopsy. Results were similar in multivariable analysis. Among subjects with both PA and CPI, those with both findings in the same core had even lower PCa risk compared with PA and CPI in different cores (univariable OR=0.68, 95% CI=0.51-0.91; multivariable OR=0.73, 95% CI=0.54-0.99). Combination of PA and CPI was associated with lower risk of high-grade PCa. CONCLUSIONS: The presence of both PA and CPI in baseline biopsies, especially in the same core, was associated with lower PCa risk and grade. The presence and topographical distribution of PA and CPI may be used in PCa risk stratification.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Moreira DM, de O Freitas DM, Nickel JC, et al. The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens. Prostate Cancer Prostatic Dis. 2017. PMID: 28585572. doi:10.1038/pcan.2017.30

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。